Accipiter Capital Management

Accipiter Capital Management as of Dec. 31, 2010

Portfolio Holdings for Accipiter Capital Management

Accipiter Capital Management holds 29 positions in its portfolio as reported in the December 2010 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
WellPoint 13.3 $16M 285k 56.86
RehabCare 9.5 $12M 490k 23.70
Aetna 8.7 $11M 349k 30.51
Gilead Sciences (GILD) 7.7 $9.4M 260k 36.24
Orchid Cellmark 6.4 $7.8M 3.9M 1.98
BioMarin Pharmaceutical (BMRN) 5.2 $6.3M 233k 26.93
Service Corporation International (SCI) 4.8 $5.9M 717k 8.25
CIGNA Corporation 4.5 $5.5M 150k 36.66
Teva Pharmaceutical Industries (TEVA) 4.5 $5.4M 104k 52.13
Coventry Health Care 4.3 $5.3M 200k 26.40
Obagi Medical Products 4.1 $5.0M 436k 11.55
Hi-Tech Pharmacal 4.0 $4.8M 194k 24.95
Zimmer Holdings (ZBH) 3.7 $4.5M 83k 53.68
MAKO Surgical 3.4 $4.1M 269k 15.22
Health Management Associates 2.9 $3.6M 376k 9.54
RTI Biologics 2.9 $3.5M 1.3M 2.67
Covidien 2.4 $2.9M 63k 45.66
Quest Diagnostics Incorporated (DGX) 2.2 $2.7M 50k 53.96
Healthsouth 2.2 $2.7M 129k 20.71
Sequenom 0.8 $940k 117k 8.03
Cleveland BioLabs 0.7 $903k 125k 7.22
Dyax 0.7 $866k 401k 2.16
NeurogesX 0.4 $538k 85k 6.36
Cytori Therapeutics 0.2 $260k 50k 5.20
AVANIR Pharmaceuticals 0.2 $224k 55k 4.07
BioTime 0.2 $208k 25k 8.32
MELA Sciences 0.1 $115k 34k 3.34
MannKind Corporation 0.1 $81k 10k 8.10
PURE Bioscience 0.0 $11k 5.0k 2.20